WALTHAM, Mass., May 15 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Deutsche Bank 34th Annual Health Care Conference being held on May 18 and 19, 2009 at the InterContinental Boston. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Mr. Zwanziger's presentation is scheduled for Tuesday, May 19, 2009 at 3:55 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the Deutsche Bank Conference website at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=IMA&item_id=2176339. A replay of the webcast will be available via the links for 30 days. During his presentation, Mr. Zwanziger may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
|SOURCE Inverness Medical Innovations, Inc.|
Copyright©2009 PR Newswire.
All rights reserved